Saama Makes State-of-the-Art Clinical Analytics Platform Available to Integrate Data from all Organizations Investigating COVID-19 Treatments

Open Invitation Issued to Corporate and Government Organizations to Mitigate Pandemic
Saama Logo

Campbell, CA (March 30, 2020) - Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today that it will contribute its AI-powered Life Science Analytics Cloud (LSAC) technology platform to establish the EndPandemic National Data Consortium. The single goal is to integrate data from all ongoing and future clinical studies to dramatically accelerate analysis on COVID-19 and SARS-CoV-2 research in order to reduce the time to find a cure by up to 50%. Saama’s unique platform will allow researchers to dynamically visualize, analyze, and interrogate data across all available programs.

“As a life sciences software company we are humbled to work with and provide technology to the brilliant professionals who tirelessly toil to solve this worldwide crisis. Working in clinical analytics, we truly understand the value derived from integrating research data and applying machine learning and predictive analytics technologies to enable better science,” said Suresh Katta, Founder and CEO of Saama Technologies. “We challenge all scientific personnel and technology companies to join the EndPandemic National Data Consortium to work together during this crisis to pool relevant data to find treatments - and hopefully a cure - for SARS-CoV-2.”

“We won't find rapid solutions for the SARS-CoV-2 pandemic with our data remaining so fragmented,” said David Shulkin, M.D., the Ninth Secretary, US Department of Veterans Affairs. “In order to adequately address this pandemic, we must share data from clinical studies across the research, healthcare, and pharma communities. By having comprehensive datasets and deep data analytics we will have the opportunity to make great progress.”

Companies interested in joining the EndPandemic National Data Consortium to collaborate and accelerate solutions to the pandemic should contact Saama at endpandemic@saama.com or 888.970.3550.

About LSAC

Life Science Analytics Cloud (LSAC) is the leading AI-powered clinical analytics platform that seamlessly integrates, curates, and animates clinical trial data, delivering more actionable insights for faster decision making.

About Saama Technologies, Inc.

Saama is the #1 AI clinical analytics platform company, enabling the life sciences industry to conduct faster and safer clinical development and regulatory programs. Today, over 50 biotech companies use Saama’s award-winning Life Science Analytics Cloud (LSAC) platform on more than 1,500 studies, including many of the top 20 pharmaceutical companies. LSAC’s rich applications facilitate an unprecedented, authoritative oversight of comprehensive clinical research data, enabling companies to file New Drug Applications (NDAs) more efficiently and bring drugs to market faster. Discover more at www.saama.com and follow Saama @SaamaTechInc.

About Carrick Capital Partners
Who We Are
A firm of enterprise software, SaaS, and technology enabled services investors and operating executives with substantial experience founding, scaling, and optimizing market leading businesses.
Our Approach
We work with management to identify and improve critical areas of their business - focusing on the priorities that align with our experiences and that will deliver the highest strategic impact in both the short-term and long-run.
Why We Are Different
We have a concentrated number of companies in our portfolio so that we can build substantial relationships with each management team and ensure our firm's commitment to each company's goals.
Latest News
Carrick Logo TM.jpg
LOS GATOS, CA (October 20, 2020) – Neeyamo Inc. is pleased to announce that Jim Madden, Co-Founder and Managing Director of Carrick Capital Partners will deliver the opening keynote at Rise Above 2020, a virtual global HR Evolution Summit taking place November 12th and 13th. Hosted by Neeyamo along with a cohort of global industry associations, the event will feature more than 50 speakers representing various avenues in the HR & payroll arena who will share their experiential insights to set a resilient HR agenda for 2021 and beyond. View the detailed event agenda here.
October 20, 2020
Accolade Logo.jpg
SEATTLE, WA (October 14, 2020) - Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, today announced financial results for the fiscal second quarter ended August 31, 2020.
October 15, 2020
Exiger Logo.jpg
NEW YORK, WASHINGTON, D.C., LONDON and SYDNEY (October 14, 2020) - Exiger, Exiger, the GRC firm transforming the global fight against financial crime and fraud, is investing to expand Exiger Intelligence, an industry-first delivery model combining award-winning technology, practical expertise and analytics-led process to address the growing challenge of managing today's data-heavy regulatory compliance enforcement, government investigations, and complex litigation environment. From eDiscovery and litigation support to compliance and risk analytics, Exiger Intelligence ushers in the next-generation of data-driven investigations and sustainable risk management solutions.
October 14, 2020